These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7009359

  • 1. Lactulose--a drug with antiendotoxin effect.
    Liehr H, Englisch G, Rasenack U.
    Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of gut-derived endotoxemia with lactulose. An experimental study].
    Hou RX.
    Zhonghua Wai Ke Za Zhi; 1991 Apr; 29(4):248-50, 272. PubMed ID: 1874117
    [Abstract] [Full Text] [Related]

  • 3. Control of endotoxinemia in liver disease by lactulose and paromomycin.
    Scevola D, Magliulo E, Trpin L, Benzi-Cipelli R, Bernardi R.
    Boll Ist Sieroter Milan; 1979 Jul 31; 58(3):242-7. PubMed ID: 518757
    [Abstract] [Full Text] [Related]

  • 4. Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice.
    Ditter B, Urbaschek R, Urbaschek B.
    Gastroenterology; 1983 Jun 31; 84(6):1547-52. PubMed ID: 6341160
    [Abstract] [Full Text] [Related]

  • 5. Galactosamine hepatitis, endotoxemia, and lactulose.
    van Vugt H, van Gool J, Thomas LL.
    Hepatology; 1983 Jun 31; 3(2):236-40. PubMed ID: 6832715
    [Abstract] [Full Text] [Related]

  • 6. Lactulose as an anti-endotoxin in liver transplantation.
    Lancet; 1989 Oct 14; 2(8668):927-8. PubMed ID: 2571854
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
    Liehr H, Heine WD.
    Hepatogastroenterology; 1981 Dec 14; 28(6):296-8. PubMed ID: 7345010
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lactulose as an antiendotoxin in experimental colitis.
    Gardiner KR, Erwin PJ, Anderson NH, McCaigue MD, Halliday MI, Rowlands BJ.
    Br J Surg; 1995 Apr 14; 82(4):469-72. PubMed ID: 7613887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experimental and clinical study of lactulose in obstructive jaundice.
    Pain JA, Bailey ME.
    Br J Surg; 1986 Oct 14; 73(10):775-8. PubMed ID: 3768644
    [Abstract] [Full Text] [Related]

  • 14. Cytoprotective effect of 16, 16' dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat.
    Stachura J, Tarnawski A, Szczudrawa J, Bogdał J, Mach T, Klimczyk B, Kirchmayer S.
    Folia Histochem Cytochem (Krakow); 1980 Oct 14; 18(4):311-7. PubMed ID: 7203270
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
    Nagakawa J, Hirota K, Hishinuma I, Miyamoto K, Sonoda J, Yamanaka T, Katayama K, Yamatsu I.
    J Pharmacol Exp Ther; 1993 Jan 14; 264(1):496-500. PubMed ID: 8423547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of oral supplementation of lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine.
    Kasravi FB, Adawi D, Molin G, Bengmark S, Jeppsson B.
    J Hepatol; 1997 Feb 14; 26(2):417-24. PubMed ID: 9059965
    [Abstract] [Full Text] [Related]

  • 19. Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.
    Lam C, Hildebrandt J, Schütze E, Rosenwirth B, Proctor RA, Liehl E, Stütz P.
    Infect Immun; 1991 Jul 14; 59(7):2351-8. PubMed ID: 1646770
    [Abstract] [Full Text] [Related]

  • 20. [Bifidum-milk and lactulose in the therapy of chronic liver diseases].
    Müting D, Reikowski J, Rosskopf U.
    Med Welt; 1980 May 30; 31(22):857-60. PubMed ID: 7392944
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.